EP1451209A4 - Tetra-,penta-,hexa- and heptapeptides having antiangiogenic activity - Google Patents
Tetra-,penta-,hexa- and heptapeptides having antiangiogenic activityInfo
- Publication number
- EP1451209A4 EP1451209A4 EP02789322A EP02789322A EP1451209A4 EP 1451209 A4 EP1451209 A4 EP 1451209A4 EP 02789322 A EP02789322 A EP 02789322A EP 02789322 A EP02789322 A EP 02789322A EP 1451209 A4 EP1451209 A4 EP 1451209A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- heptapeptides
- hexa
- penta
- tetra
- antiangiogenic activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/000,711 US20030105025A1 (en) | 2001-10-31 | 2001-10-31 | Tri-and tetrapeptides having antiangiogenic activity |
US540 | 2001-10-31 | ||
US10/000,540 US20030119745A1 (en) | 2001-10-31 | 2001-10-31 | HEXA- and heptapeptides having antiangiogenic activity |
US7 | 2001-10-31 | ||
US263811 | 2002-10-04 | ||
US10/263,811 US20030105022A1 (en) | 2001-10-31 | 2002-10-04 | Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity |
PCT/US2002/034760 WO2003037266A2 (en) | 2001-10-31 | 2002-10-30 | Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1451209A2 EP1451209A2 (en) | 2004-09-01 |
EP1451209A4 true EP1451209A4 (en) | 2009-06-03 |
Family
ID=32659830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02789322A Withdrawn EP1451209A4 (en) | 2001-10-31 | 2002-10-30 | Tetra-,penta-,hexa- and heptapeptides having antiangiogenic activity |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1451209A4 (en) |
JP (1) | JP2005512980A (en) |
CA (1) | CA2466152A1 (en) |
MX (1) | MXPA04004135A (en) |
UY (1) | UY27523A1 (en) |
WO (1) | WO2003037266A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030125260A1 (en) * | 2001-10-31 | 2003-07-03 | Fortuna Haviv | Tetra-and pentapeptides having antiangiogenic activity |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780426A (en) * | 1995-06-07 | 1998-07-14 | Ixsys, Incorporated | Fivemer cyclic peptide inhibitors of diseases involving αv β3 |
US5932545A (en) * | 1997-03-17 | 1999-08-03 | Abbott Laboratories | Antiangiogenic drug to treat cancer, arthritis and retinopathy |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9910639A (en) * | 1998-05-22 | 2002-01-15 | Abbott Lab | Anti-angiogenic drugs comprising peptide |
-
2002
- 2002-10-30 EP EP02789322A patent/EP1451209A4/en not_active Withdrawn
- 2002-10-30 CA CA002466152A patent/CA2466152A1/en not_active Abandoned
- 2002-10-30 WO PCT/US2002/034760 patent/WO2003037266A2/en active Application Filing
- 2002-10-30 UY UY27523A patent/UY27523A1/en not_active Application Discontinuation
- 2002-10-30 MX MXPA04004135A patent/MXPA04004135A/en unknown
- 2002-10-30 JP JP2003539612A patent/JP2005512980A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780426A (en) * | 1995-06-07 | 1998-07-14 | Ixsys, Incorporated | Fivemer cyclic peptide inhibitors of diseases involving αv β3 |
US5932545A (en) * | 1997-03-17 | 1999-08-03 | Abbott Laboratories | Antiangiogenic drug to treat cancer, arthritis and retinopathy |
Non-Patent Citations (1)
Title |
---|
MIYASAKI KT ET AL: "Bactericidal Activities of Synthetic Human Leukocyte Cathepsin G-Derived Antibiotic Peptides and Congeners against Actinobacillus actinomycetemcomitans and Capnocytophaga sputigena", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 37, no. 12, December 1993 (1993-12-01), pages 2710 - 2715, XP002523772 * |
Also Published As
Publication number | Publication date |
---|---|
MXPA04004135A (en) | 2004-07-08 |
WO2003037266A3 (en) | 2003-12-11 |
UY27523A1 (en) | 2003-05-30 |
CA2466152A1 (en) | 2003-05-08 |
JP2005512980A (en) | 2005-05-12 |
WO2003037266A2 (en) | 2003-05-08 |
EP1451209A2 (en) | 2004-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2380983B (en) | Modular overhead console assembly | |
EP1401817A4 (en) | Isoquinoline compounds having antiinfective activity | |
EP1250025A4 (en) | Headphone | |
AU148399S (en) | A headset | |
HK1065217A1 (en) | Headphone | |
GB0006350D0 (en) | Joystick controller | |
GB0002847D0 (en) | Ampligier arrangement | |
HUP0402171A3 (en) | Pyrazolopyrimidinone derivatives having pde7-inhibitory activity | |
AU143395S (en) | Robot | |
EP1445062A4 (en) | Work support | |
EP1450841A4 (en) | Tri-, tetra-, and penta-peptides having antiangiogenic activity | |
IL154364A0 (en) | Arylalkane-sulfonamides having endothelin-antagonist activity | |
AU145539S (en) | A headset | |
PL368745A1 (en) | Peptides having antiangiogenic activity | |
GB2383410B (en) | Joystick | |
EP1451209A4 (en) | Tetra-,penta-,hexa- and heptapeptides having antiangiogenic activity | |
GB0010443D0 (en) | A floor protector | |
AU2002353922A1 (en) | Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity | |
AU144210S (en) | Torch | |
GB0214196D0 (en) | Interference suppression | |
GB0027235D0 (en) | Arc location | |
GB0025955D0 (en) | Work support | |
PT2177530E (en) | Octapeptide having antiangiogenic activity | |
GB0101116D0 (en) | Activity board accessory | |
GB0028656D0 (en) | Improved bucket attachment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040528 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1068900 Country of ref document: HK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20090506 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20090805 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1068900 Country of ref document: HK |